Hunan Jingfeng Pharmaceutical (000908) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hunan Jingfeng Pharmaceutical (000908) has a cash flow conversion efficiency ratio of -3.332x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.78 Million ≈ $18.41 Million USD) by net assets (CN¥-37.76 Million ≈ $-5.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hunan Jingfeng Pharmaceutical - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Hunan Jingfeng Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000908 total liabilities for a breakdown of total debt and financial obligations.
Hunan Jingfeng Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Jingfeng Pharmaceutical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ASRock Inc
TW:3515
|
-0.040x |
|
China Resources and Environment Co Ltd
SHG:600217
|
0.199x |
|
SKF India Limited
NSE:SKFINDIA
|
0.116x |
|
Sun Create Electronics Co., Ltd
SHG:600990
|
0.058x |
|
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira
SA:INTB3
|
0.150x |
|
Changzhou Tenglong Auto Parts
SHG:603158
|
0.028x |
|
Guangxi Wuzhou Communications Co Ltd
SHG:600368
|
0.040x |
|
Lelon Electronics Corp
TW:2472
|
0.048x |
Annual Cash Flow Conversion Efficiency for Hunan Jingfeng Pharmaceutical (1999–2024)
The table below shows the annual cash flow conversion efficiency of Hunan Jingfeng Pharmaceutical from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Hunan Jingfeng Pharmaceutical worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥-15.13 Million ≈ $-2.21 Million |
CN¥-5.55 Million ≈ $-812.28K |
0.367x | +260.81% |
| 2023-12-31 | CN¥-153.68 Million ≈ $-22.49 Million |
CN¥35.06 Million ≈ $5.13 Million |
-0.228x | -139.76% |
| 2022-12-31 | CN¥214.83 Million ≈ $31.44 Million |
CN¥123.27 Million ≈ $18.04 Million |
0.574x | +51.85% |
| 2021-12-31 | CN¥327.73 Million ≈ $47.96 Million |
CN¥123.83 Million ≈ $18.12 Million |
0.378x | +188.76% |
| 2020-12-31 | CN¥638.18 Million ≈ $93.39 Million |
CN¥-271.68 Million ≈ $-39.76 Million |
-0.426x | -2385.47% |
| 2019-12-31 | CN¥1.94 Billion ≈ $284.15 Million |
CN¥36.17 Million ≈ $5.29 Million |
0.019x | -84.81% |
| 2018-12-31 | CN¥2.86 Billion ≈ $418.81 Million |
CN¥350.94 Million ≈ $51.35 Million |
0.123x | +110.21% |
| 2017-12-31 | CN¥2.60 Billion ≈ $380.45 Million |
CN¥151.65 Million ≈ $22.19 Million |
0.058x | +1136.37% |
| 2016-12-31 | CN¥2.61 Billion ≈ $382.27 Million |
CN¥12.32 Million ≈ $1.80 Million |
0.005x | -88.52% |
| 2015-12-31 | CN¥2.25 Billion ≈ $329.02 Million |
CN¥92.37 Million ≈ $13.52 Million |
0.041x | -80.17% |
| 2014-12-31 | CN¥994.04 Million ≈ $145.46 Million |
CN¥205.93 Million ≈ $30.13 Million |
0.207x | +131.95% |
| 2013-12-31 | CN¥5.31 Million ≈ $776.82K |
CN¥-3.44 Million ≈ $-503.70K |
-0.648x | -10996.71% |
| 2012-12-31 | CN¥-60.15 Million ≈ $-8.80 Million |
CN¥351.50K ≈ $51.44K |
-0.006x | +99.93% |
| 2011-12-31 | CN¥790.82K ≈ $115.72K |
CN¥-6.87 Million ≈ $-1.01 Million |
-8.689x | -3203.30% |
| 2010-12-31 | CN¥57.85 Million ≈ $8.46 Million |
CN¥-15.21 Million ≈ $-2.23 Million |
-0.263x | -122.84% |
| 2009-12-31 | CN¥100.67 Million ≈ $14.73 Million |
CN¥-11.88 Million ≈ $-1.74 Million |
-0.118x | -228.87% |
| 2008-12-31 | CN¥338.64 Million ≈ $49.55 Million |
CN¥31.02 Million ≈ $4.54 Million |
0.092x | -40.95% |
| 2007-12-31 | CN¥336.95 Million ≈ $49.31 Million |
CN¥52.26 Million ≈ $7.65 Million |
0.155x | -9.89% |
| 2006-12-31 | CN¥336.40 Million ≈ $49.23 Million |
CN¥57.90 Million ≈ $8.47 Million |
0.172x | +195.38% |
| 2005-12-31 | CN¥329.66 Million ≈ $48.24 Million |
CN¥-59.49 Million ≈ $-8.71 Million |
-0.180x | +60.83% |
| 2004-12-31 | CN¥339.45 Million ≈ $49.67 Million |
CN¥-156.37 Million ≈ $-22.88 Million |
-0.461x | -958.22% |
| 2003-12-31 | CN¥419.38 Million ≈ $61.37 Million |
CN¥22.51 Million ≈ $3.29 Million |
0.054x | +59.52% |
| 2002-12-31 | CN¥522.69 Million ≈ $76.49 Million |
CN¥17.59 Million ≈ $2.57 Million |
0.034x | -45.02% |
| 2001-12-31 | CN¥498.41 Million ≈ $72.93 Million |
CN¥30.50 Million ≈ $4.46 Million |
0.061x | +222.29% |
| 2000-12-31 | CN¥500.54 Million ≈ $73.24 Million |
CN¥-25.05 Million ≈ $-3.67 Million |
-0.050x | -278.13% |
| 1999-12-31 | CN¥485.43 Million ≈ $71.03 Million |
CN¥13.64 Million ≈ $2.00 Million |
0.028x | -- |
About Hunan Jingfeng Pharmaceutical
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the f… Read more